Cystic Fibrosis Papers of the Year, 2013-2014.
Paediatr Respir Rev
; 16 Suppl 1: 9-11, 2015 Oct.
Article
em En
| MEDLINE
| ID: mdl-26410284
ABSTRACT
Studies published in the last year in the field of cystic fibrosis have provided more data on the safety and efficacy of a number of therapies, including mutation-specific drugs. There have also been a number of publications on monitoring of early lung disease including the use of lung clearance index and magnetic resonance scanning. Evidence suggests early lung changes may remain relatively static over the first year of life. There are important outcome differences across national patient registries and there is also the increasing recognition of psychological illnesses and possible drug interactions as treatment becomes more complicated and survival improves.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Monitoramento de Medicamentos
/
Fibrose Cística
Tipo de estudo:
Diagnostic_studies
Limite:
Adolescent
/
Adult
/
Child
/
Child, preschool
/
Humans
Idioma:
En
Revista:
Paediatr Respir Rev
Assunto da revista:
PEDIATRIA
Ano de publicação:
2015
Tipo de documento:
Article